Objective To screen severe hand, foot and mouth disease(SHFMD) differentially expressed genes(DEGs), and for provide theoretical basis for the early identification and timely treatment of SHFMD by high-throughput transcriptome sequencing technology(RNA sequencing, RNA-seq). And to reduce the mortality and improve the prognosis of the disease.Methods A total of 15 PBMC samples were collected from 5 SHFMD patients, 5 MHFMD(mild hand, foot and mouth disease, MHFMD) patients and 5 healthy control(HC), during May 2014 and August 2014, in the third people's hospital of shenzhen. Using the RNA-seq technology we sequenced the RNA of the PBMC, on the basis of RPKM(Reads Per Kilobase of exon model per Million mapped reads) multiples and expression level fold-change, and screened the differentially expressed genes. Furthermore, we confirmed the expression levels of the DEGs by quantitative real-time PCR(q RT-PCR) and enzyme-linked immunosorbent assay(ELISA).Results RNA-seq found 117 DEGs between SHFMD and MHFMD, including 108 up-regulated genes and 9 down-regulated genes; and 26 DEGs between SHFMD and HC, including 14 up-regulated genes and 12 down-regulated genes. The two groups of DEGs had 8 genes in common, of which S100A8, S100A12, IL-8 and IL-1? were up-regulated, while TNFRSF13 C, IL-7R, THBS1 and VEGFA were down-regulated. And q RT-PCR and ELISA detection results are consistent with the results of RNA-seq(P<0.05).Conclusions 1.RNA-seq technology successfully establishment of gene expression profiles of HFMD. 2.Up-regulation of S100A8, S100A12, IL-8, IL-1? and down-regulated TNFRSF13 C, IL-7R, THBS1, VEGFA were SHFMD differentially expressed genes, is expected to become the predictor of severe HFMD. |